Search details
1.
Targeting the activin receptor 1C on CD4+ T cells for cancer immunotherapy.
Oncoimmunology
; 13(1): 2297503, 2024.
Article
in English
| MEDLINE | ID: mdl-38235319
Results
1 -
1
de 1
1
Next >
>>